Abstract. Ovarian follicular development in mammals is the complex process including endocrine, paracrine and autocrine.
hypophysectomized rat [3] , and thus this process does not require pituitary gonadotropins. Initiation of follicle growth from the primordial to primary stage is characterized both by changes of granulosa cell shape and an increase in oocyte size [4] .
Apart from paracrine factors of granulosa and theca cell origin, growth differentiation factor-9 (GDF-9) secreted by the oocyte has recently been shown to play a role in follicular development. GDF-9-deficient mice, similar to steel panda mutants of the kit ligand gene [5] , display an arrest of follicle growth at the primary follicle stage [6] . The ovaries of GDF-9 null animals lack several theca cell markers including CYP17 and c-kit [7] . These reports indicated that oocyte derived-factor G D F -9 p l a y a n i m p o r t a n t r o l e f o r e a r l y folliculogenesis in mammalian ovary.
The development of the four basic stages of ovarian follicles, i.e. the primordial, primary, secondary and tertiary or Graafian follicle, is accompanied by qualitative and quantitative changes in the microvascular bed. There are few blood vessels in the cortical area where preantral, i.e. primordial, and primary follicles are assembled. As the granulosa cells proliferate, stromal cells surrounding the follicle from a sheath of connective tissue cells, known as the theca folliculi. The theca folliculi differentiates into two layers, the theca interna, which is an inner vascular layer with cuboidal secretory cells, and the theca externa, the outer layer of connective tissue cells [8] . Entering the theca interna, the arterioles break up into a rich network of capillaries that builds a basket-like network around the avascular stratum granulosum [9] . The movement of nutrients and small macromolecules from the blood vessels of the theca into the follicular fluid is essential for development of the ovum and follicle. Because all capillaries remain outside the basement membrane of the follicle, the granulosa layer remains avascular until about the time of ovulation. The development of preovulatory follicles is associated with increased density of blood vessels within the theca cell layers surrounding the follicle [10] . One of the earliest signs of follicular atresia or degeneration is the a s s o c i a t i o n o f r e d u c e d D N A s y n t h e s i s i n endothelial cells with reduced vascularity of the follicle [11] . In addition, early atretic follicles regenerate when placed in culture, suggesting that the follicle remains in its atretic state due to a decrease in vascularity which limits access to nutrients, substrates and trophic hormones [12] . The differences in vascular development appear to be crucial in selection of the ovulatory follicle.
Promotion of Early Folliculogenesis by GDF-9 Gene Injection
The development of ovarian follicles is a complex process dependent upon endocrine regulation involving hypophyseal gonadotropins and regulated locally by ovarian factors. Initiation of follicular growth involves the transformation of primordial follicles from a quiescent, growtharrested state to a growth-committed state. This process is characterized by differentiation and proliferation of granulosa cells and by enlargement of the oocyte [1, 13] , and is regulated by several growth factors [2, 14, 15] . Of intraovarian growth factors, attention has been focused on members of the TGFβ superfamily [16] . Of these, growth differentiation factor-9 (GDF-9) is a growth factor secreted by the oocyte [16] . Gdf-9 mRNA and GDF-9 protein are not only expressed at the primary follicle stage but are also present in oocytes throughout growth to the ovulatory phase [7, 17] . In GDF-9 knockout mice [6] , the absence of GDF-9 result in a block in folliculogenesis at the type 3b stage (late, one-layer primary follicle stage), indicating that GDF-9 is associated with early folliculogenesis. In the present study, using our protocol for injection of gene fragments, we investigated the involvement of GDF-9 in early folliculogenesis in pigs. Since porcine GDF-9 cDNA has not been cloned, we first cloned the cDNA of porcine GDF-9 and examined how the direct ovarian injection of the cloned GDF-9 gene affected early folliculogenesis.
Based on the nucleotide sequences of bovine and ovine GDF-9 cDNAs, we amplified GDF-9 cDNA from a porcine ovarian cDNA library and deduced the amino acid encoded thereby (Fig. 1) . The open reading frame (ORF) of porcine GDF-9 cDNA is 1335 bp long (encoding 445 amino acids, including the stop codon). Porcine GDF-9 has an ORF homology of 84.5%, 71.6%, 72.6% and 72.7% with its bovine (GenBank accession no. AB058416), ovine (GenBank accession no. AF078545), rat (GenBank accession no. X81899) and mouse (GenBank accession no. BC052667) counterparts, respectively (Table 1) . For the putative mature protein, the corresponding homology reaches 98%, 97%, 90% and 88%, respectively. Porcine GDF-9 contains six potential N-glycosylation sites at asparagines 105, 162, 186, 254, 268 and 327, and a putative tetrabasic proteolytic processing site (RHRR) at amino acids 305-308 (Fig. 2 ). In addition, multiple cysteines presumably important for forming the disulfide bonds to maintain the secondary structure of GDF-9 are also conserved. The GDF-9 ORF is composed of pro-and mature regions separated by a tetrabasic cleavage site (RHRR). Comparison of the amino acid sequence of porcine GDF-9 with those of its bovine, ovine, rat and mouse counterparts indicated that the putative mature GDF-9 protein is highly conserved (>88%) among these species. Multiple cysteines are conserved in all five species, and presumably are essential for the formation of disulfide bonds to stabilize the unique "handshaped" protein [18] . In addition, one and five Nlinked glycosylation sites are found in the mature and pro-region of porcine GDF-9, respectively.
To investigate the function of porcine GDF-9 in early folliculogenesis, we performed direct ovarian injection of porcine GDF-9 gene fragments. After injection of GDF-9 gene fragments, the percentage of primordial follicles in the ovaries decreased significantly compared with that in the control. The percentages of primary, secondary and tertiary follicles in the ovaries injected with GDF-9 gene fragments were significantly higher than those in the control (Fig. 3) . Quantitative real-time PCR analysis showed that GDF-9 mRNAs were greatly expressed in the GDF-9 gene fragment-treated ovaries than in the controls. The results from the present study indicated that the injection of GDF-9 gene fragments increased the number of primary and secondary follicles, concomitant with a decrease in the number of primordial follicles. Our findings are consistent with the previous by reported findings that in vivo application of GDF-9 led to an increase in the number of primary and preantral follicles [19] .
In conclusion, porcine GDF-9 was cloned for here the first time and injection of its gene fragments into the ovary resulted in an increase in the number of primary, secondary and tertiary follicles. These results demonstrated the enhancement of the transition from the primordial to primary follicle stages. Current ovarian stimulation protocols for infertility treatment influence antral follicle growth mainly by using gonadotropins [20] . However, in poor responders to gonadotropin stimulation [21] , it is difficult to enhance the ovulation rate using current infertility therapy. Oocyte donation is the only option for such patients desiring pregnancy [22] . Ovaries from most women with premature ovarian failure contain primordial follicles [23] . Therefore, injection of GDF-9 gene fragments into the ovary may be an effective method to make primordial follicles grow.
Artificail Control of Follicular Development and Atresia by VEGF Gene Injection
Ovarian follicular angiogenesis is initiated early during follicular development and continues throughout follicular growth [24] ; blood vessels in thecal cell layer increase in number and size as the follicle develops, but do not penetrate the granulosa cell layer while the basal membrane surrounding the follicle remains intact [24, 25] . Under such circumstances, although small preantral follicles have no vascular supply of their own, antral follicles acquire a vascular sheath in the theca cell or layer [26] . As the antrum develops in the follicle, the thecal layer acquires a vascular sheath that consists of two capillary networks located in the theca interna and externa. Both capillary networks are connected to each other, and all capillary blood exists from the theca interna into small vessels that become connected with the ovarian stromal veins [27] . Because all capillaries remain outside the basement membrane of the follicle, the granulosa layer remains avascular until about the time of ovulation. At the last stage of folliculogenesis, increased vascularization of individual follicles results in preferential delivery of gonadotropins, after which blood flow to individual follicles plays an instrumental role in the selective maturation of preovulatory follicles [28] . Thus, differences in vascular development appear to be crucial in selection of the ovulatory follicle.
A recent study reported that vascular endothelial growth factor (VEGF), known as a potent mitogen for endothelial cells [29] and as a stimulator of vascular permeability [30, 31] , was expressed in granulosa cells isolated from pig follicles [10, 32] . It has been demonstrated that the short-term inhibition of angiogenesis after anti-VEGF antibody administration during the later growth phase of the dominant follicle interferes with its normal development [33] . Moreover the blocking of VEGF action by treatment with a soluble truncated form of the fms-like tyrosine kinase (Flt-1) receptor resulted in an 87% decrease of proliferation in the theca of secondary and tertiary follicles, a reduction in endothelial cell area and a marked decline in Flt-1 mRNA expression [34] . Therefore, VEGF is thought to be a central factor in regulating thecal angiogenesis during follicular development. In turn, these findings may raise the possibility that the enhancement of circular commitment of VEGF around the follicles could positively affect their development process (follicle selection). Recently, to evaluate the importance of vascular events (vascular permeability and neovascularization) in follicle rupture and luteal development, sequential experiments were designed in which vehicle, angiogenic inhibitors (TNP-470 or angiostatin) or soluble VEGFR1 (VEGF antagonist) were injected directly into the preovulatory follicle of rhesus monkeys during spontaneous menstrual cycle [35, 36] . We tested this hypothesis by inducing extraproduction of VEGF by direct ovarian injection of its gene fragments in pigs. Large follicles (larger than 5 mm in diameter) protruding on the ovarian surface were observed in the ovaries of eCG-treated gilts with or without VEGF gene fragment injection, but the mean number of large follicles significantly increased in the VEGF gene fragment-treated ovaries (14.8 ± 1.89/ovary v.s 8.3 ± 0.75/ovary, Fig. 4 ). Semiquantitative RT-PCR and ELISA assay revealed that, in the VEGF-treated ovary, VEGF mRNA was extraexpressed in the granulosa cells of follicles, and that VEGF proteins increased in the follicular fluid (Fig. 5) . On the contrary, in the VEGFuntreated ovary, VEGF mRNA expression and protein were low in the granulosa cells and follicular fluid, respectively. These results show the first evidence that exogenous VEGF gene is incorporated into the granulosa cells of follicles and contributes to the production of VEGF protein.
In histological examination we observed that the vascular density in the theca interna of follicles at different developmental stages in the VEGF-treated ovary increased two-fold compared with that in the VEGF-untreated ovary. These changes clearly indicated stimulatory signs of thecal angiogenesis associated with a significant amount of relative tissue areas covered by vessels (Fig.6) . In this study, our findings demonstrated that the occurrence of thecal angiogenesis via folliclederived VEGF during follicular development promoted perifollicular vascularization and a resultant increase in the size and number of follicles. Thus, our data supported the concept that follicular growth is associated with and perhaps critically dependent on the degree of vascular development [27] . Importantly, the increase in vascular density surrounding the antral follicles contributes to the inhibition of atresia (Fig.7) . Early atretic follicles can regenerate when placed in culture, suggesting that the follicle remains in the atretic state due to a decrease in vascularity that limits access to nutrients, substrates and trophic hormones [12] . Our findings demonstrated that promotion of thecal vascularization by VEGF contributed to the decrease in atretic follicles. In pig ovaries, as in those of other species, apoptotic cell death is a mechanism by which follicular atresia is induced [37] . VEGF reduces tumor cell apoptosis, whereas inhibition with anti-VEGF neutralizing antibodies induces apoptosis directly in tumor cells [38] . Thus, in addition to its roles in angiogenesis and vessel permeability, VEGF may act as a survival factor for the granulosa cells of follicles, and then may suppress atresia of the antral follicles, leading to an increased number of ovulated oocytes.
VEGF binds to its receptors, such as Flt-1, Flt-4, Flk-1 and neuropilin-1, in the vascular endothelial cells [39] [40] [41] . Of these receptors, Flt-1 and Flk-1 both bind to VEGF with high affinity [29] . Although the expressions of Flt-1 and Flk-1 mRNAs were detected in the ovary [10, 42, 43] , it is s t i l l u n k n o w n w h e t h e r F l t -1 o r F l k -1 i s predominantly committed to thecal angiogenesis. Our results showed that extraexpression of VEGF in the granulosa cells increased the expression of Flt-1 mRNA but not that of Flk-1 in the thecal cells, indicating that Flt-1 may contribute in accelerating the developmental regulation of the capillary network in the theca interna during follicular development, and that the VEGF-Flt system is associated with a functional vascular system in the thecal layer.
In conclusion, our findings demonstrated that direct injection of the VEGF gene into the ovary results in the development of the vascular network in the thecal cell layers and can promote the resultant follicular development. The oocytes collected from preovulatory follicles of the porcine ovaries treated with VEGF gene injection were proven to be normal in fertility and cleavage when examined by in vitro fertilization. From the present study using pigs, we concluded that gene treatment in combination with hormonal treatment can significantly increase the number of follicles with healthy oocytes by rescuing the atretic follicles.
Future Prospects
The injection of GDF-9 and VEGF gene fragments into the ovary resulted in an increase in the number of primary, secondary, tertiary and preovulatory follicles. This study may contribute to ovarian disorders, including polycystic ovarian syndrome (PCOS), follicular cyst formation, luteal phase d e f e c t s ( L P D ) a n d b e n i g n a n d m a l i g n a n t neoplasms [44] . Moreover, understanding the interaction between the ovarian vasculature and angiogenic factors during infertility therapy, such as controlled ovarian stimulation (COS) protocols, a n d a s s o c i a t e d s i d e -e f f e c t s , i . e . o v a r i a n hyperstimulation syndrome (OHSS), is important. PCOS is an aberrant condition of the ovary originally described by Stein and Leventhal [45] . While PCOS has been associated with healthy fertile women of reproductive age [46] , it represents an astonishing 75% of cases involving anovulatory infertility [47] . Current ovarian stimulation protocols for infertility treatment influence antral follicle growth mainly by using gonadotropins [48] . However, in poor responders to gonadotropin stimulation [49] , it is difficult to enhance the ovulation rate using current infertility therapy. Oocyte donation is the only option for such patients desiring pregnancy [50] . Furthermore, we suggested that these results may offer a protocol to develop a novel therapy for the prevention and treatment of infertility associated with ovarian dysfunction. 
